Updated Clinical Activity of Graspa Versus Native l-Asparaginase in Combination with Cooprall Regimen in Phase 3 Randomized Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517) - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2015

Updated Clinical Activity of Graspa Versus Native l-Asparaginase in Combination with Cooprall Regimen in Phase 3 Randomized Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)

Yves Bertrand
  • Function : Author
  • PersonId : 899520
Nicolas Blin
Emmanuelle Tavernier
  • Function : Author
Francoise Mazingue
  • Function : Author
Genevieve Plat
  • Function : Author
José Fernandes
  • Function : Author
Poiree Maryline
  • Function : Author
Luc Fornecker
  • Function : Author
Mathilde Hunault
Thibault Leguay
  • Function : Author
Alina Ferster
Cecile Bonin
  • Function : Author
Iman El Hariry
  • Function : Author

Abstract

Conference: 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL - DEC 05-08, 2015
Not file

Dates and versions

hal-01290425 , version 1 (18-03-2016)

Identifiers

  • HAL Id : hal-01290425 , version 1

Cite

André Baruchel, Yves Bertrand, Xavier Thomas, Nicolas Blin, Emmanuelle Tavernier, et al.. Updated Clinical Activity of Graspa Versus Native l-Asparaginase in Combination with Cooprall Regimen in Phase 3 Randomized Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517). Blood, 2015, 126 (23), pp.3723. ⟨hal-01290425⟩
171 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More